[Enzymatic activity of cathepsin B, cathepsin B and L, plasmin, trypsin and collagenase in hepatocellular carcinoma]. 2002

Monika Niewczas, and Leszek Paczek, and Marek Krawczyk, and Jacek Pawlak, and Irena Bartłomiejczyk, and Barbara Górnicka
Klinika Immunologii, Transplantologii i Chorób Wewnetrznych Instytutu Transplantologii AM w Warszawie.

Hepatocellular carcinoma is one of the most common malignancies worldwide. Invasiveness of this tumour seems to be related to degradation of extracellular matrix. Such proteolytic enzymes as: cathepsin B and L, plasmin, collagenase and trypsin are thought to play a pivotal role in this process. Enzymatic activity depends on balance between enzymes and their inhibitors and--moreover--on interactions among these enzymes. The purpose of our study was to evaluate enzymatic activity of cathepsin B, cathepsin B and L, plasmin, collagenase and trypsin in patients with hepatocellular carcinoma in liver tissue and in peripheral blood. Then correlations between activity of enzymes (mentioned above) and clinical status, pathological findings and laboratory tests were assessed. Our study was conducted on 14 patients who underwent surgery because of hepatocellular carcinoma. Tissue samples were obtained during surgery from neoplastic area and from non-neoplastic area. Peripheral blood was withdrawn before surgery and within early post-operative period. Proteolytic activity of these enzymes was determined with use of fluorometric assay. Enzymatic activity in tissue samples was referred to protein concentration (BCA assay) and to DNA concentration (fluorometric assay). RESULTS Proteolytic activity of plasmin and trypsin in neoplastic tissue were significantly lower as compared to non-neoplastic area of these patients (p = 0.0356; p = 0.0412, respectively). Activity of the remaining enzymes: cathepsin B, cathepsin B and L and collagenase did not differ significantly. No difference was demonstrated between activity of enzymes in peripheral blood withdrawn before surgery and in postoperative period. There was a statistically significant inverse correlation between serum AFP level and enzymatic activity of cathepsin B, cathepsin B and L and collagenase in tumor tissue. Lower activity of all investigated enzymes was observed in tumor tissue of HBV related hepatocellular carcinoma in comparison with the remaining tissue samples. Correlation between patients age and activity of enzymes was not statistically significant. CONCLUSIONS Although the evaluation of presented enzymatic profile did not allow for the assessment of associations between investigated enzymes, our results demonstrated correlations between proteolytic activity of enzymes and serum AFP level, viral status, but it requires further investigations.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002401 Cathepsin B A lysosomal cysteine proteinase with a specificity similar to that of PAPAIN. The enzyme is present in a variety of tissues and is important in many physiological and pathological processes. In pathology, cathepsin B has been found to be involved in DEMYELINATION; EMPHYSEMA; RHEUMATOID ARTHRITIS, and NEOPLASM INVASIVENESS. Cathepsin B-Like Proteinase,Cathepsin B1,Cathepsin B Like Proteinase,Proteinase, Cathepsin B-Like
D002403 Cathepsins A group of lysosomal proteinases or endopeptidases found in aqueous extracts of a variety of animal tissues. They function optimally within an acidic pH range. The cathepsins occur as a variety of enzyme subtypes including SERINE PROTEASES; ASPARTIC PROTEINASES; and CYSTEINE PROTEASES. Cathepsin
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D005260 Female Females
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D005470 Fluorometry An analytical method for detecting and measuring FLUORESCENCE in compounds or targets such as cells, proteins, or nucleotides, or targets previously labeled with FLUORESCENCE AGENTS. Fluorimetry,Fluorometric Analysis,Analysis, Fluorometric
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas

Related Publications

Monika Niewczas, and Leszek Paczek, and Marek Krawczyk, and Jacek Pawlak, and Irena Bartłomiejczyk, and Barbara Górnicka
February 1987, The Biochemical journal,
Monika Niewczas, and Leszek Paczek, and Marek Krawczyk, and Jacek Pawlak, and Irena Bartłomiejczyk, and Barbara Górnicka
July 1995, Human pathology,
Monika Niewczas, and Leszek Paczek, and Marek Krawczyk, and Jacek Pawlak, and Irena Bartłomiejczyk, and Barbara Górnicka
January 1999, Rheumatology (Oxford, England),
Monika Niewczas, and Leszek Paczek, and Marek Krawczyk, and Jacek Pawlak, and Irena Bartłomiejczyk, and Barbara Górnicka
January 1981, Methods in enzymology,
Monika Niewczas, and Leszek Paczek, and Marek Krawczyk, and Jacek Pawlak, and Irena Bartłomiejczyk, and Barbara Górnicka
January 2012, Archives of gerontology and geriatrics,
Monika Niewczas, and Leszek Paczek, and Marek Krawczyk, and Jacek Pawlak, and Irena Bartłomiejczyk, and Barbara Górnicka
May 2023, Foods (Basel, Switzerland),
Monika Niewczas, and Leszek Paczek, and Marek Krawczyk, and Jacek Pawlak, and Irena Bartłomiejczyk, and Barbara Górnicka
November 2022, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.],
Monika Niewczas, and Leszek Paczek, and Marek Krawczyk, and Jacek Pawlak, and Irena Bartłomiejczyk, and Barbara Górnicka
July 2020, Journal of experimental & clinical cancer research : CR,
Monika Niewczas, and Leszek Paczek, and Marek Krawczyk, and Jacek Pawlak, and Irena Bartłomiejczyk, and Barbara Górnicka
January 1986, Voprosy meditsinskoi khimii,
Monika Niewczas, and Leszek Paczek, and Marek Krawczyk, and Jacek Pawlak, and Irena Bartłomiejczyk, and Barbara Górnicka
September 1951, Nature,
Copied contents to your clipboard!